Resident Publications

We encourage residents to take leadership roles in research projects.  Residents have the opportunity to collaborate with clinical, cancer biology, and medical physics faculty within the

Department of Radiation Oncology, and with faculty of many other Duke departments.

2017

 

  • Hong JC, Rahimy E, Gross CP, Shafman T, Hu X, Yu JB, Ross R, Finkelstein SE, Dosoretz A, Park HS, Soulos PR, Evans SB. Radiation Dose and Cardiac Risk in Breast Cancer Treatment: An Analysis of Modern Radiotherapy Including Community Settings. Pract Radiat Oncol. 2017 Jul 20. pii: S1879-8500(17)30199-6. doi: 10.1016/j.prro.2017.07.005. Epub ahead of print. PMID: 28888675.
  • Rahimy E, Hong JC, Gross CP, Hu X, Shafman T, Conner H, Ross R, Dosoretz A, Evans SB. Increased number of beam angles is associated with higher cardiac dose in adjuvant fixed gantry intensity-modulated radiation therapy of left-sided breast cancer. Int J Radiat Oncol Biol Phys. 2017 Jun 27. pii: S0360-3016(17)33517-4. doi: 10.1016/j.ijrobp.2017.06.2451. Epub ahead of print. PMID: 28864402.
  • Gensheimer M*, Hong JC*, Chang-Halpenny C, Eclov NCW, To J, Murphy JD, Wakelee HA, Neal J, Le QT, Hara WY, Quon A, Maxim PG, Graves EE, Olson MR, Diehn M, Loo BW. Mid-radiotherapy PET/CT for prognostication and detection of early progression in patients with stage III non-small cell lung cancer. Radiother Oncol. 2017 Aug 19. pii: S0167-8140(17)32514-8. doi: 10.1016/j.radonc.2017.08.007. PMID: 28830717. *Equal contributors.
  • Chino F, Peppercorn J, Rushing C, Kamal A, Altomare I, Samsa G, Zafar Y. “Going for Broke”: Out-of-Pocket Costs, Financial Distress and Underinsurance in Cancer Care. e-pub 8/10/2017. JAMA Oncology, doi:10.1001/jamaoncol.2017.2148
  • Chino F, Willett C, Palta M, Czito, Chapter 15:  Colorectal Cancer, Gastrointestinal Malignancies: A Practical Guide on Treatment Techniques, Springer International Publishing, 2017 DOI: 10.1007/978-3-319-64900-9
  • Spiegel D, Palta M, Uronis H. (2017). The Role of Chemotherapy and Radiation Therapy in the Management of Gastric Adenocarcinoma. Surgical Clinics of North America. 97(2):421-435.
  • Spiegel DY. Breast Cancer: Biology or Stage? Int J Radiat Oncol Biol Phys. 2017. 98(5):974-975.
  • Tandberg DJ, Kelsey CR, D’Amico TA, Crawford J, Chino JP, Tong BC, Ready NE, Wright A. Patterns of Failure Following Surgery for Non-Small Cell Lung Cancer Invading the Chest Wall, Clinical Lung Cancer. 2017 July; 18(4):259-265.
  • Huang J, Chen M, Whitley M, Kuo H, Xu E, Walens A, Mowery YM, Van Mater D, Eward W, Cardona D, Luo L, Ma Y, Lopez O, Nelson C, Robinson-Hamm J, Reddy A, Dave S, Gersbach C, Dodd R, Kirsch DG. Generation and comparison of CRISPR/Cas9 and Cre-mediated genetically engineered mouse models of sarcoma. Nature Communications. 2017 Jul; 8:15999.
  • Ali, M, Kaltenbrun, E, Anderson, GR, Stephens, SJ, Arena, S, Bardelli, A, Counter, CM, and Wood, KC; Codon bias imposes a targetable limitation on KRAS-drive therapeutic resistance; Nature Communications; 8:15617; June 2017.
  • Natesan D, Hong JC, Foote J, Sosa JA, Havrilesky L, Chino J. Increasing Utilization of Intensity Modulated Radiation Therapy in Vulvar Cancer: National Practice Patterns 2004-2012. J Radiat Oncol. 2017 May 18. DOI 10.1007/s13566-017-0312-9.
  • Mowery YM, Salama JK, Zafar SY, Moore HG, Willett CG, Czito BG, Hopkins MB, Palta M. Neoadjuvant long-course chemoradiation remains strongly favored over short-course radiotherapy by radiation oncologists in the United States. Cancer. 2017 Apr; 123(8):1434-1441.
  • Hong JC, Foote J, Broadwater G, Gaillard S, Havrilesky LJ, Chino JP. Impact of chemotherapy and radiotherapy on management of early stage clear cell and papillary serous carcinoma of the uterus. Int J Gynecol Cancer. Int J Gynecol Cancer. 2017 Apr 3. doi: 10.1097/IGC.0000000000000926. PMID: 28375927.
  • Hong JC, Foote J, Broadwater G, Sosa J, Gaillard S, Havrilesky LJ, Chino JP. A data-derived treatment duration goal for cervical cancer: Should 8 weeks remain the goal in the era of concurrent chemoradiation? JCO Clinical Cancer Informatics 2017 Mar 28. doi: 10.1200/CCI.16.00072.
  • Natesan D, Hong JC, Foote J, Sosa JA, Gaillard S, Havrilesky L, Chino J. Primary vs. Preoperative Radiation for Locally Advanced Vulvar Cancer: A National Cancer Data Base (NCDB) analysis. Int J Gynecol Cancer. Int J Gynecol Cancer. 2017 Mar 23. doi: 10.1097/IGC.0000000000000938. PMID: 28333840.
  • Tandberg DJ, Holt T, Kelsey CR. Plasma Metabolites and risk of Radiation-induced Esophagitis: A Secondary Analysis from a Prospective Study, Anticancer Research. 2017 Feb; 37(2):719-726.
  • Torok JA, Gu L, Tandberg DJ, Wang X, Harpole Jr. DH, Kelsey CR, Salama JK. Patterns of Distant Metastases Following Surgical Management of Non-Small Cell Lung Cancer, Clinical Lung Cancer. 2017; 18(1):57-70.
  • Jacobs C, Jafari ME. Early Results of Lung Cancer Screening and Radiation Dose Assessment by Low-Dose CT at a Community Hospital. Clin Lung Cancer. 2017 Feb 2. pii: S1525-7304(17)30040-2. http://dx.doi.org/10.1016/j.cllc.2017.01.011
  • Hong JC, Salama JK. The expanding role of stereotactic body radiation therapy in oligometastatic solid tumors: what do we know and where are we going? Cancer Treat Rev. 2017 Jan;52:22-32. doi: 10.1016/j.ctrv.2016.11.003. PMID: 27886588.
     

2016

  • Stephens, SJ, Thomas, S, Rizzieri, DA, Horwitz, ME, Chao, NJ, Engemann, AM, Lassiter, M, and Kelsey, CR; Myeloablative conditioning and total body irradiation in AML: Balancing survival and pulmonary toxicity; Adv Radiat Oncol; 1(4); Oct-Dec 2016; 272-280.  
  • Hong JC, Czito BG, Willett CG, Palta M. A current perspective on stereotactic body radiation therapy for pancreatic cancer. Onco Targets Ther. 2016 Oct 31;9:6733-6739. PMID: 27826200.
  • Stahl JM, Hong JC, Lester-Coll NH, Kann BH, Wilson LD, Higgins SA, Evans SB. Chest Wall Deformity in the Radiation Oncology Clinic. Anticancer Res. 2016 Oct;36(10):5295-5300. PMID: 27798891.
  • Mowery YM and JK Salama. A Multidisciplinary Approach to Larynx Cancer: One Size Does Not Fit All. J Oncol Pract. 2016 Aug;12(8): 725-6.
  • Boyer MJ, Ricardi U, Ball D, and Salama JK. Ablative Approaches for Pulmonary Metastases. Thoracic Surgery Clinics 2016 Feb; 26(1): 19-34. doi: http://dx.doi.org/10.1016/j.thorsurg.2015.09.004
  • Hong JC, Salama JK. Dose escalation for unresectable locally advanced non-small cell lung cancer: end of the line? Transl Lung Cancer Res 2016; 5(1): 126-133. doi: 10.3978/j.issn.2218-6751.2016. PMID: 26958507.
  • Tandberg DJ, Osmond GW, Czito BG. Melanoma involving the surgical scar following surgery and craniospinal irradiation for childhood medulloblastoma: case report and literature review. Case Reports in Clinical Pathology. 2016;3(1):43-46.
  • Torok JA, Palta M, Willett CG, Czito BG. Nonoperative management of rectal cancer. Cancer. 2016, Jan 1, 122(1):34-41; Epub 2015.
  • Moding EJ, Mowery YM and DG Kirsch. Opportunities for Radiosensitization in the SBRT Era. The Cancer Journal: The Journal of Principles & Practice of Oncology. 2016.
  • Soo MS, Jarosz JA, Wren AA, Soo AE, Mowery YM, Johnson KS, Yoon SC, Kim C, Hwang  ES, Keefe FJ, Shelby RA. Imaging-Guided Core-Needle Breast Biopsy: Impact of Meditation and Music Interventions on Patient Anxiety, Pain, and Fatigue. Journal of the American College of Radiology. 2016.
  • Mowery YM, Horton JK. “Preoperative partial breast.” Short Course Breast Radiotherapy: A Comprehensive Review of Hypofractionation, Partial Breast, and Intra-operative Irradiation, 1st edition. Editors Arthur DW, Vicini F, Wazer DE, Khan AJ. Springer International Publishing. 2016.
  • Mowery YM, Yoo S, and Blitzblau RC. “Chapter 30. Breast Cancer.” Treatment Planning in Radiation Oncology, 4th edition. Editors Khan F, Gibbons J, and Sperduto P. Lippincott Williams & Wilkins, Wolters Kluwer Health. 2016.
  •  Evans MK, Sauer SJ, Nath S, Robinson TJ, Morse MA, Devi GR. X-linked Inhibitor of Apoptosis Protein Mediates Tumor Cell Resistance to Antibody-Dependent Cellular Cytotoxicity. Cell Death Disease. 2016 Jan 28;7:e2073.

     

2015

  • Olson AC, Coleman CN, Hahm SM, DeWeese TL, Shulman LN, Chabner BA, Chao N, Martei YM, Mundt AJ, Grover S. A Roadmap for a New Academic Pathway for Global Radiation Oncology. Int J Radiat Oncol Biol Phys. 2015 Nov 93(3):493-496.
  • Grover S, Balogun OD, Yamoah K, Groen R, Shah M, Rodin D, Martei YM, Olson AC, Slone JS, Shulman LN, Coleman CN, Hahn SM. Training Global Oncologists: Addressing the Global Cancer Control Problem. Front Oncol. 2015 Apr 8;5:80. Pubmed ID 25905040.
  • Mowery YM and RC Blitzblau. The UK HeartSpare Study (Stage IB): Randomised comparison of a voluntary breath-hold technique and prone radiotherapy after breast conserving surgery: Bartlett FR, Colgan RM, Donovan EM, et al (Royal Marsden NHS Foundation Trust, Sutton, UK; et al) Radiother Oncol 114:66-72, 2014. Breast Diseases: A Year Book Quarterly. 2015 Oct; 26(3): 237–239.
  • Mowery YM. A Primer on Medical Education in the United States through the Lens of a Current  Resident Physician. Journal of Thoracic Disease. 2015 Oct; 7(10).
  • Boyle J, Lee WR. Surgery is Inappropriate for Very High Risk Prostate Cancer: Pro. Oncology (Williston Park) 2015. (Accepted for publication).
  • Boyle J, Czito B, Willett C, Palta M. Adjuvant Radiation Therapy for Pancreatic Cancer: A Review of the Old and the New. J Gastrointest Oncol 2015. (Accepted for publication).
  • Torok JA, Wu Y, Prosnitz LR, Kim GJ, Beaven AW, Diehl LF, Kelsey CR. Low-dose consolidation radiation therapy for early stage unfavorable Hodgkin lymphoma. Intern J Radiat Oncol, Biol, Phys 2015; 92(1): 54-9 [PMID 25863754].
  • Salama JK, Palta M, Torok JA. The multidisciplinary management of early stage cervical esophageal cancer. In: Saba NF, El-Rayes B, eds. Esophageal Cancer: prevention, diagnosis and therapy. 1st ed. New York, NY: Springer International Publishing; 2015: 173-185.
  • Torok JA, Palta M, Willett CG, Czito BG. Principles of radiation therapy in rectal cancer. In Cai Q, Xu H, El-Rayes B, Kooby D, Landry J, eds. Gastrointestinal Malignancies: Diagnosis and Treatment. Singapore: World Scientific Publishing; 2015.
  • Torok JA, Perez BA, Czito BG, Willett CG, Yin F, Palta M. Cancers of the gastrointenstinal tract. In Khan FM, Gerbi BJ, Sperduto P eds. Treatment Planning in Radiation Oncology. 4th ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2015.
  • Robinson TJ, Dinan MA, Li Y, Lee WR, Reed SD. Longitudinal trends in costs of palliative radiation for metastatic prostate cancer. J Palliat Med. 2015 Nov; 18(11):933-9. Epub 2015 Aug 4.
  • Tandberg DJ, Craciunescu O, Kelsey CR. Radiation therapy for cutaneous T-cell lymphomas.  Dermatol Clin. 2015 Oct;33(4):703-713.
  • Boyle JM, Tandberg DJ, Chino JP, D'Amico TA, Ready NE, Kelsey Cr. Smoking history predicts for increased risk of second primary lung cancer: A comprehensive analysis. Cancer. 2015 Fe 15; 121(4): 598-604.
  • Zafar SY, Chino F, Ubel PA, Rushing C, Samsa G, Altomare I, Nicolla J, Schrag D, Tulsky JA, Abernethy AP, Peppercorn JM. The utility of cost discussions between patients with cancer and oncologists. Am J Manag Care. 2015 Sep;21(9):607-15.

2014

  • Vivas EX, Wegner R, Conley G, Torok J, Heron DE, Kabolizadeh P, Burton S, Ozhasoglu C, Quinn A, Hirsch BE. Treatment outcomes in patients treated with CyberKnife radiosurgery for vestibular schwannoma. Otolaryngology & Neurotology 2014; 35(1): 162-70 [PMID 24335934.
  • Gill BS, Kim H, Houser C, Olson AC, Kelley J, Edwards RP, Comerci J, Sukumvanich P, Olawaiye AB, Huang M, Courtney-Brooks M, Beriwal S. Image-based three-dimensional conformal brachytherapy for medically inoperable endometrial carcinoma. Brachytherapy. 2014 Nov-Dec; 13(6):542-7. Pubmed ID 25127122.
  • Mowery YM and RC Blitzblau. Whole-breast radiation therapy: the long and short of it. Int J Radiat Oncol Biol Phys. 2014 Dec; 90(5):990-2.
  • Boyer MJ, Salama JK, and Lee WR. Palliative radiotherapy for prostate cancer. Oncology 2014 Apr; 28(4): 306-312. PMID: 24839802.
  • Boyle J, Beaven A, Diehl, Prosnitz L, Kelsey C. Improving Outcomes in Advanced Diffuse Large B-cell Lymphoma: Systemic Approaches and Radiotherapy. Oncology (Williston Park). 2014 Dec 15;28(12).
  • Boyle J, Craciunescu O, Steffey B, Cai J, Chino J. Safety, Feasibility, and Early Clinical Outcomes of Dose Escalation Using a Simultaneous Integrated Boost in Patients with Locally Advanced Gynecologic Malignancies. Gynecol Oncol. 2014 Sep 2.
  • Boyle J, Craciunescu O, Steffey B, Cai J, Chino J. Body mass index, dose to organs at risk during vaginal brachytherapy, and the role of three-dimensional CT-based treatment planning. Brachytherapy. 2014 Jul-Aug;13(4):332-6.
  • Boyle J, Dorth, Craciunescu O, Steffey B, Light K, Chino J. Simultaneous Integrated Boost to Pelvic and Paraaortic Nodes from Cervical Cancer Improves the Dosimetric Therapeutic Ratio [abstract]. In: American Society for Radiation Oncology Annual Meeting 2014. September 14-17; San Francisco, CA; Fairfax, VA: ASTRO; 2014.
  • Torok JA, Palta M, Czito BG, Willett CG. Intraoperative radiotherapy in the treatment of gastrointestinal malignancies. Translational Cancer Research 2014; 3(6): 537-540 [not indexed in pubmed].
  • Torok JA, Czito BG, Willett CG, Palta M. Future of radiotherapy delivery in rectal cancer-European and US approaches. Oncology & Hematology Review 2014; 10(2): 139-143 [not indexed in pubmed].
  • Robinson TJ, and Koontz BF. Redox-Active Therapeutics. Chapter: Oxidative Stress and Erectile Dysfunction in the Treatment of Prostate Cancer. Springer. Editors: Batinic-Haberle, Reboucas, Spasojevic, St.Clair, and Watner. 2014.
  • Wattson DA, Tanguturi SK, Spiegel DY, Niemierko A, Biller BM, Nachtigall LB, Bussière MR, Swearingen B, Chapman PH, Loeffler JS, Shih HA. Outcomes of proton therapy for patients with functional pituitary adenomas. Int J Radiat Oncol Biol Phys. 2014 Nov 1;90(3):532-9.
  • Bestvina CM, Zullig LL, Rushing C, Chino F, Samsa GP, Altomare I, Tulsky J, Ubel P, Schrag D, Nicolla J, Abernethy AP, Peppercorn J, Zafar SY. Patient-oncologist cost communication, financial distress, and medication adherence. J Oncol Pract. 2014 May;10(3):162-7. doi: 10.1200/JOP.2014.001406.
  • Chino F, Peppercorn J, Taylor DH Jr, Lu Y, Samsa G, Abernethy AP, Zafar SY. Self-reported financial burden and satisfaction with care among patients with cancer. Oncologist. 2014 Apr;19(4):414-20. doi: 10.1634/theoncologist.2013-0374. Epub 2014 Mar 25.

2013

  • Homa N, Salinas-Mondrigan R, Forte E, Robinson TJ, Garcia-Blanco MA and Luftig MA. Epstein-Barr virus induces global changes in cellular mRNA isoform usage important for the maintenance of latency. Journal of Virology. 2013 Nov; 87(22):122291-301. Epub 2013 Sep 11.
  • Donnelly E, Refaat T, Gentile M, Boyle J, Helenowski I, Rademaker A, Lurain J, Schink J, Singh D, Strauss JB, Small W Jr. Evaluation of Outcomes in Patients With Carcinoma of the Cervix Treated With Concurrent Radiation and Cisplatin Versus Cisplatin/5-FU Compared With Radiation Alone. Am J Clin Oncol. 2013 Jul 24. [Epub ahead of print].
  • Boyle J, Dorth, Craciunescu O, Steffey B, Light K, Chino J. Initial Safety and Feasibility of Dose Escalation Using a Simultaneous Integrated Boost in Patients With Locally Advanced Gynecologic Malignancies [abstract]. In: American Society for Radiation Oncology Annual meeting; 2013. September 22-25; Atlanta, GA; Fairfax, VA: ASTRO; 2013
  • Coen JJ, Paly JJ, Niemierko A, Kaufman DS, Heney NM, Spiegel DY, Efstathiou JA, Zietman AL, Shipley WU. Nomograms predicting response to therapy and outcomes after bladder-preserving trimodality therapy for muscle-invasive bladder cancer. Int J Radiat Oncol Biol Phys. 2013 Jun 1; 86(2):311-6.
  • Wattson DA, Tanguturi SK, Spiegel DY, Niemierko BMK, Biller LB, Nachtigall LB, Swearingen B, Chapman PH, Loeffler JS, Shish HA. Outcomes of Proton Radiation Therapy for Patients with Functional Pituitary Adenomas. Int J Radiat Oncol Biol Phys. 2013. 87 (2):S264.
  • Tandberg DJ, Gee NG, Chino JP, D’Amico TA, Berry MF, Ready NE, Coleman RE, Higgins KA, Kelsey CR. Are Discordant PET and Pathological Assessments of the Mediastinum in Non-Small Cell Lung Cancer Significant? J Thorac Cardiovasc Surg. 2013 Oct;146(4):796-801.
  • Cabrera AR, Cuneo KC, Desjardins A, Sampson JH, McSherry F, Herndon JE 2nd, Peters KB, Allen K, Hoang JK, Chang Z, Craciunescu O, Vredenburgh JJ, Friedman HS, Kirkpatrick JP. Concurrent Stereotactic Radiosurgery and Bevacizumab in Recurrent Malignant Gliomas: A Prospective Trial. Int J Radiat Oncol Biol Phys. 2013 May 29. [Epub ahead of print]
  • Cuneo KC, Mito JK, Javid MP, Ferrer JM, Kim Y, Lee WD, Bawendi MG, Brigman BE, Kirsch DG. Imaging primary mouse sarcomas after radiation therapy using cathepsin-activatable fluorescent imaging agents. Int J Radiat Oncol Biol Phys. 2013 May 1;86(1):136-142.
  • Dorth JA, Patel PR, Broadwater G, Brizel DM. Incidence and risk factors of significant carotid artery stenosis in asymptomatic survivors of head and neck cancer after radiotherapy. Head Neck. 2013 Apr 2. doi: 10.1002/hed.23280. [Epub ahead of print]
  • Kelsey CR, Fornili M, Ambrogi F, Higgins K, Boyd JA, Biganzoli E, Demicheli R. Metastasis Dynamics for Non-Small-Cell Lung Cancer: Effect of Patient and Tumor-Related Factors. Clin Lung Cancer. 2013 Mar 15. doi:pii: S1525-7304(13)00028-4. 10.1016/j.cllc.2013.01.002. [Epub ahead of print]
  • Pepek JM, Chino JP, Willett CG, Palta M, Blazer Iii DG, Tyler DS, Uronis HE, Czito BG.  Preoperative chemoradiotherapy for locally advanced gastric cancer. Radiat Oncol. 2013 Jan 4;8:6.
  • Pepek JM, Willett CG, Czito BG. Technical considerations in radiation therapy for gastroesophageal junction cancer. Semin Radiat Oncol. 2013 Jan;23(1):51-59.
  • Perez BA, Ghafoori AP, Lee CL, Johnston SM, Li Y, Moroshek JG, Ma Y, Mukherjee S, Kim Y, Badea CT, Kirsch DG. Assessing the radiation response of lung cancer with different gene mutations using genetically engineered mice. Front Oncol. 2013;3:72.
  • Willett CG, Czito BG, Palta M. ACT II: treatment of anal cancer comes full circle. Lancet Oncol. 2013 Apr 8. doi:pii: S1470-2045(13)70121-9. Epub ahead of print].
  • Zhong J, Palta M, Willett CG, McCall SJ, Bulusu A, Tyler DS, White RR, Uronis HE, Pappas TN, Czito BG. The role of local excision in invasive adenocarcinoma of the ampulla of Vater. J Gastrointest Oncol. 2013 Mar;4(1):8-13.

2012

  • Robinson TJ, Forte E, Salinas-Mondrigan R, Puri S, Marengo M, Garcia-Blanco MA and Luftig MA. SplicerEX: a tool for the automated detection and classification of mRNA changes from conventional and splice-sensitive microarray expression data. RNA 2012 Aug;18(8):1435-45. Epub 2012 Jun 26.
  • Simmons LA, Dinan MA, Robinson TJ, Snyderman R. Personalized medicine is more than genomic medicine: confusion over terminology impedes progress towards personalized healthcare. Future Medicine. 2012, Jan 9(1): 85-91.
  • Cho AH, Jiang X, Mann DM, Kawamoto K, Robinson TJ, Wang N, McCarthy JJ, Woodward M, Ginsburg GS. A more rapid approach to systematically assessing published associations of genetic polymorphisms and disease risk: type 2 diabetes as a test case. Comparative Effectiveness Research. 2012 Jan 2012(2): 1-20.
  • Dinan MA, Robinson TJ, Zagar TM, Scales CD, Curtis LH, Reed SD, Schulman KA, Lee RW. Changes in the initial Treatment of Prostate Cancer among Medicare Beneficiaries 1999-2007. Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5): e781-6. Epub 2012 Feb 11.
  • Efstathiou JA, Spiegel DY, Shipley WU, Heney NM, Kaufman DS, Niemierko A, Coen JJ, Skowronski RY, PalyJJ, McGovern FJ, Zietman AL. Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH Experience. European Urology. 2012. 61(4):705-711
  • Sioshansi S, Ehdaivand S, Cramer C, Lomme M, Price L and Wazer DE. Triple Negative Breast Cancer is Associated with an Increased Risk of Residual Invasive Carcinoma after Lumpectomy. Cancer 2012, August 15; 118(16): 3893-8, Epub, Jan 3, 2012.
  • Cabrera, A.R., Cuneo, K.C., Vredenburgh, J.J., Sampson, J.H., Kirkpatrick, J.P. Stereotactic radiosurgery and bevacizumab for recurrent glioblastoma multiforme. Journal of the National Comprehensive Cancer Network, 2012 Jun 1;10(6):695-699.
  • Cuneo KC, Dash RC, Wilke LG, Horton JK, Koontz* BF. Risk of invasive breast cancer and ductal carcinoma in-situ in women with atypical papillary lesions of the breast. The Breast Journal 2012 Sep;18(5):475-478.
  • Cuneo KC, Riedel RF, Dodd LG, Harpole DH, Kirsch DG.  Pathologic complete response of a malignant peripheral nerve sheath tumor in the lung treated with neoadjuvant ifosfamide and radiation therapy. J Clin Oncol. 2012 Oct 1;30(28):291-293.
  • Cuneo KC, Vredenburgh JJ, Sampson JH, Reardon DA, Desjardins A, Peters KL, Kirkpatrick JP. Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):2018-2024.
  • Cuneo KC, Zagar TM, Brizel DM, Yoo DS, Hoang JK, Chang Z, Wang Z, Yin FF, Das SK, Green S, Ready N, Bhatti MT, Kaylie DM, Becker A, Sampson JH, Kirkpatrick JP. Stereotactic radiotherapy for malignancies involving the trigeminal and facial nerves. Technol Cancer Res Treat. 2012 Jun;11(3):221-228.
  • Dinan MA, Robinson TJ, Zagar TM, Scales CD Jr, Curtis LH, Reed SD, Lee WR, Schulman KA. Changes in initial treatment for prostate cancer among medicare beneficiaries, 1999-2007. Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):e781-6.
  • Dorth JA, Prosnitz LR, Broadwater G, Diehl LF, Beaven AW, Coleman RE, Kelsey CR. Impact of Consolidation Radiation Therapy in Stage III-IV Diffuse Large B-cell Lymphoma with Negative Post-Chemotherapy Radiologic Imaging. Int J Radiat Oncol Biol Phys. 2012 84( 3):762-767.
  • Higgins KA, Chino JP, Berry M, Ready N, Boyd J, Yoo DS, Kelsey CR. Local failure in resected N1 lung cancer: implications for adjuvant therapy. Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):727-733.
  • Higgins KA, Hoang JK, Roach MC, Chino J, Yoo DS, Turkington TG, Brizel DM. Analysis of pretreatment FDG-PET SUV parameters in head-and-neck cancer: tumor SUVmean has superior prognostic value. Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):548-553.
  • Higgins, K. A., Jenny K. Hoang, Michael C. Roach, Junzo Chino, David S. Yoo, Timothy G. Turkington, David M Brizel. Analysis of Pretreatment FDG-PET SUV Parameters in Head-and-Neck Cancer: Tumor SUVmean has Superior Prognostic Value. Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):548-53.
  • Lee C-L, Moding EJ, Cuneo KC, Li Y, Sullivan JM, Mao L, Washington I, Jeffords LB, Rodrigues RC, Ma Y, Das S, Kontos CD, Yongbaek K, Rockman HA, Kirsch DG. p53 Functions in Endothelial Cells to Prevent Radiation-Induced Myocardial Injury in Mice. Science Signaling 2012 Jul 24;5(234):ra52.
  • Mito JK, Ferrer JM, Brigman BE, Lee CL, Dodd RD, Eward WC, Marshall LF, Cuneo KC, Carter JE, Ramasunder S, Kim Y, Lee WD, Griffith LG, Bawendi MG, Kirsch DG. Intraoperative detection and removal of microscopic residual sarcoma using wide-field imaging. Cancer. 2012 Nov 1;118(21):5320-30
  • Oh DS, Adamson DC, Kirkpatrick JP. Targeted radiotherapy for malignant gliomas. Curr Drug Discov Technol. 2012 Dec;9(4):268-79.
  • Palta M, Patel P, Broadwater G, Willett C, Pepek J, Tyler D, Zafar SY, Uronis H, Hurwitz H, White R, Czito B. Carcinoma of the ampulla of Vater: patterns of failure following resection and benefit of chemoradiotherapy. Ann Surg Oncol. 2012 May;19(5):1535-1540.
  • Palta M, S Yoo, J Adamson, J Horton. Preoperative Single Fraction Partial Breast Radiotherapy for Early Stage Breast Cancer. Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):37-42.
  • Patel P, Lee WR. Radiotherapy following radical prostatectomy. Expert Rev Anticancer Ther. 2012 Jul;12(7):973-9. doi: 10.1586/era.12.66. Review.
  • Patel PR, Salama JK. Reirradiation for recurrent head and neck cancer. Expert Rev Anticancer Ther. 2012 Sep;12(9):1177-89.
  • Patel PR, Yoo DS, Niibe Y, Urbanic JJ, Salama JK. A call for the aggressive treatment of oligometastatic and oligo-recurrent non-small cell lung cancer. Pulm Med. 2012;2012:480961.
  • Patel PR, Yoo S, Broadwater G, Marks LB, Miles EF, D'Amico TA, Harpole D, Kelsey CR. Effect of increasing experience on dosimetric and clinical outcomes in the management of malignant pleural mesothelioma with intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):362-368.
  • Roach MC, Turkington TG, Higgins KA, Hawk TC, Hoang JK, Brizel DM. FDG-PET assessment of the effect of head and neck radiotherapy on parotid gland glucose metabolism. Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):321-6.
  • Yue, J., Yang, Y., Cabrera, A.R., Sun, X., Zhao, S., Xie, P., Zheng, J., Ma, L., Fu, Z., Yu, J. Measuring tumor hypoxia with 18F-FETNIM PET in esophageal squamous cell carcinoma: a pilot clinical study. Diseases of the Esophagus 2012 25(1):54-61.
  • Zagar TM, White RR, Willett CG, Tyler DS, Papavassiliou P, Papalezova KT, Guy CD, Broadwater G, Clough RW, Czito BG. Resected Pancreatic Neuroendocrine Tumors: Patterns of Failure and Disease-Related Outcomes With or Without Radiotherapy. Int J Radiat Oncol Biol Phys. 2012 Jan 21.

2011

  • Miller HB, Robinson TJ, Gordan R, Hartemink AJ, Garcia-Blanco MA. Identification of Tat-SF1 cellular targets by exon array analysis reveals dual roles in transcription and splicing. RNA 2011 Apr;17(4): 665-74. Epub 2011 Jan 31.
  • Boyle J, Donnelly E, Lurain J, Schink J, Singh D, Gentile M,Weitner B, Strauss J, Small W. Patterns of Recurrence After Definitive Radiation Therapy for Locoregionally-Confined Cervical Cancer. In: American Society for Radiation Oncology Annual meeting; 2011. October 2-6; Miami, FL; Fairfax, VA: ASTRO; 2011.
  • Diavolitsis V, Shirazi H, Boyle J, Hayes J. Residents' educational needs during transition into radiation oncology residency. J Am Coll Radiol. 2011 Nov;8(11):785-8.
  • Boyle, J., Diavolitsis, Small, W. Role of Radiation Therapy in Uterine-confined Endometrial Carcinoma. Pract Radiat Oncol. 2011 Jul-Sep;1(3):196-203.
  • Diavolitsis, V., Rademaker. A., Boyle, J., Kang, J., Kiel, K., Mulcahy, M., Small, W., Change in Creatinine Clearance over time Following Upper Abdominal Irradiation: A Dose Volume Histogram Multivariate Analysis. Am J Clin Oncol. 2011 Feb;34(1):53-7.
  • Cabrera A.R., Lee W.R., Madden R., Sims E., Hoang J.K., White L.E., Marks L.B., Chino J.P. Incorporating gross anatomy education into radiation oncology residency:  A two year curriculum with evaluation of resident satisfaction. Journal of the American College of Radiology. 2011 8:335-340.
  • Cabrera AR, Kelsey, C.R., Marks, L.B. Small cell lung cancer. British Medical Journal (Best Practice). 2011.
  • Dorth JA, Chino JP, Prosnitz LR, Diehl LF, Beaven AW, Coleman RE, Kelsey CR. The impact of radiation therapy in patients with diffuse large B-cell lymphoma with positive post-chemotherapy FDG-PET or gallium-67 scans. Ann Oncol. 2011 Feb;22(2):405-410.
  • Higgins KA, Chino JP, Ready N, Onaitis MW, Berry MF, D'Amico TA, Kelsey CR. Persistent N2 disease after neoadjuvant chemotherapy for non-small-cell lung cancer. J Thorac Cardiovasc Surg. 2011 Nov;142(5):1175-9.
  • Palta M, Riedel RF, Vredenburgh JJ, Cummings TJ, Green S, Chang Z, Kirkpatrick JP. Primary meningeal rhabdomyosarcoma. Sarcoma. 2011;2011:312802.
  • Palta M, Willett C, Czito B. Role of radiation therapy in patients with resectable pancreatic cancer. Oncology (Williston Park). 2011 Jul;25(8):715-21, 727. Review.
  • Palta M, WR Lee. The Development of Oncology Treatment Guidelines: An Analysis of the National Guidelines Clearinghouse. Practical Radiation Oncology; 2011;1:33­37.
  • Pepek JM, Chino JP, Marks LB, D'Amico TA, Yoo DS, Onaitis MW, Ready NE, Hubbs JL, Boyd J, Kelsey CR. How well does the new lung cancer staging system predict for local/regional recurrence after surgery?: A comparison of the TNM 6 and 7 systems. J Thorac Oncol. 2011 Apr;6(4):757-761.

2010

  • Higgins KA, Willett CG, Czito BG. Nonoperative management of rectal cancer: current perspectives. Clin Colorectal Cancer. 2010 Apr;9(2):83-8.
  • Palta M, Christopher C, Mendenhall N. Angiosarcoma after breast conserving therapy: Long term outcomes with hyperfractionated radiotherapy. Cancer 2010; 116:1872-1878.
  • Pepek JM, Willett CG, Czito BG. Radiation therapy advances for treatment of anal cancer. J Natl Compr Canc Netw. 2010 Jan;8(1):123-129. Review.
  • Pepek JM, Willett CG, Wu QJ, Yoo S, Clough RW, Czito BG. Intensity-modulated radiation therapy for anal malignancies: a preliminary toxicity and disease outcomes analysis. Int J Radiat Oncol Biol Phys. 2010 Dec 1;78(5):1413-1419.
  • Zagar TM, Blackwell S, Crawford J, D'Amico T, Christensen JD, Sporn TA, Kelsey CR. Preoperative radiation therapy and chemotherapy for pulmonary blastoma: A case report. J Thorac Oncol. 2010 Feb;5(2):282-3.
  • Zagar TM, Higgins KA, Miles EF, Vujaskovic Z, Dewhirst MW, Clough RW, Prosnitz LR, Jones EL. Durable palliation of breast cancer chest wall recurrence with radiation therapy, hyperthermia, and chemotherapy. Radiother Oncol. 2010 Dec;97 (3):535-540.
  • Zagar TM, Oleson JR, Vujaskovic Z, Dewhirst MW, Craciunescu OI, Blackwell KL, Prosnitz LR, Jones EL. Hyperthermia for locally advanced breast cancer. Int J Hyperthermia. 2010;26(7):618-24. Review.
  • Zagar TM, Oleson JR, Vujaskovic Z, Dewhirst MW, Craciunescu OI, Blackwell KL, Prosnitz LR, Jones EL. Hyperthermia combined with radiation therapy for superficial breast cancer and chest wall recurrence: a review of the randomised data. Int J Hyperthermia. 2010;26(7):612-7. Review.
  • Zagar TM, Willett CG, Czito BG. Intensity-modulated radiation therapy for anal cancer: toxicity versus outcomes. Oncology (Williston Park). 2010 Aug;24(9):815-23, 828. Review.
  • Arora H, Paunesku T, Doty C, Yuan Y, Boyle J, Rabatic B, Woloschak G. Titania nanocomposites. Kumar C, ed. Nanocomposites for Life Sciences. Baton Rouge: Wiley. Print. Nanomaterials for the Life Sciences ser. 2010.
  • Cramer CK, Friedman JH, Amick NM. Olfaction and Apathy in Parkinson's Disease. Parkinsonism and Related Discorders 2010, Feb; 16(2): 124-6. Epub, Sept 26, 2009.
  • Zietman AL, Bae K, Slater JD, Shipley WU, Efstathiou JA, Coen JJ, Bush DA, Lunt M, Spiegel DY, Skowronski RY, Jabola BR, Rossi CJ. A randomized trial comparing conventional dose conformal radiation therapy with high-dose in early stage adenocarcinoma of the prostate. Journal of Clinical Oncology. 2010. 28(7):1106-1111.
  • Igdem S, Spiegel DY, Efstathiou JA, Zietman AL, Miller R, Poortmans D, Unsal D. Prostatic duct adenocarcinoma: clinical characteristics, treatment options and outcomes – a Rare Cancer Network study. Onkologie. 2010. 33(4):169-173.
  • Efstathiou JA, Coen JJ, Spiegel DY, Niemierko A, Kaufman DS, Heney NM, McDougal WS, McGovern FJ, Zietman AL, Shipley WU. 15-year outcomes of selective bladder preservation for invasive bladder cancer: The Massachusetts General Hospital experience. Proc. of the 2010 ASCO Genitourinary Cancers Symposium. 2010 March 5-7; San Francisco, CA. Abstract #273.

2009

  • XuFeng R, Boyer MJ, Shen H, Li Y, Yu H, Gao Y, Yang Q, Wang Q, and Cheng T. ADAR1 is required for hematopoietic progenitor cell survival via RNA editing.Proc Natl Acad Sci USA 2009 Oct 20; 106(42): 17763-8. Doi: 10.1073/pnas.0903324106. Epub 2009 Oct 2.
  • Boyle J, Wu A, Arora H, Paunesku T, Woloschak G. The Radiosensitizing Effects Of Titanium-dioxide Nanoparticles In Vitro Int J Radiat Oncol Biol Phys Vol. 75, Issue 3 1 November 2009, Page S570.
  • Diavolitsis V, Boyle J, Singh DK, Small W Jr. The role of adjuvant radiation in endometrial cancer. Oncology (Williston Park). 2009 Apr 15;23(4):342-9.
  • Boyle J, Wu A, Arora H, Paunesku T, Woloschak G. The Radiosensitizing Effects Of Titanium-dioxide Nanoparticles In Vitro [abtract] In: American Society for Therapeutic Radiology and Oncology Annual meeting; 2009 November 1-5; Chicago, IL; Fairfax, VA: ASTRO; 2009.
  • Boyle J, Wu A, Arora H, Paunesku T, Woloschak G. Use of titanium-dioxide nanoparticles for improved cytotoxicity of radiation therapy in vitro [abtract]. In: American Association for the Advancement of Cancer Research 100th Annual Meeting; 2009 April 18-22; Denver, CO. Philadelphia, PA: AACR; 2009.
  • Boyle J, Wu A, Arora H, Paunesku T, Woloschak G. Use of titanium-dioxide nanoparticles for improved cytotoxicity of radiation therapy in vitro [abtract] In: Robert H. Lurie 20th Annual Poster Session; 2009 June 16; Chicago, IL; Robert H Lurie Cancer Center.
  • Chino J, Schroeck FR, Sun L, Lee WR, Albala DM, Moul JW, Koontz BF. Robot-assisted laparoscopic prostatectomy is not associated with early postoperative radiation therapy. BJU Int. 2009 Nov;104(10):1496-500.
  • Chino JP, Sampson JH, Tucci DL, Brizel DM, Kirkpatrick JP. Paraganglioma of the head and neck: long-term local control with radiotherapy. Am J Clin Oncol. 2009 Jun;32(3):304-7.
  • Czito BG, Pepek JM, Meyer JJ, Yoo S, Willett CG. Intensity-modulated radiation therapy for anal cancer. Oncology (Williston Park). 2009 Nov 15;23(12):1082-1089. Review
  • Ghafoori P, Yoshimuru T, Turpie B, Masli S. Increased IkBa expression is essential for the tolerogenic property of TGF-b-exposed APCs. FASEB Journal. 2009 Jul;23 (7):2226-34.
  • Higgins K, Chino JP, Marks LB, Ready N, D'Amico TA, Clough RW, Kelsey CR. Preoperative chemotherapy versus preoperative chemoradiotherapy for stage III (N2) non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2009 Dec 1;75(5):1462-7.
  • Koontz BF, Chino J, Lee WR, Hahn CA, Buckley N, Huang S, Kim J, Reagan R, Joyner R, Anscher MS. Morbidity and prostate-specific antigen control of external beam radiation therapy plus low-dose-rate brachytherapy boost for low, intermediate, and high-risk prostate cancer. Brachytherapy. 2009 Apr-Jun;8(2):191-6
  • Nelson JW, Ghafoori AP, Willett CG, Tyler DS, Pappas TN, Clary BM, Hurwitz HI, Bendell JC, Morse MA, Clough RW, Czito BG. Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys. 2009 Jan 1;73 (1):148-153. (Featured in 2009 IJROBP Issue Highlights, p. A117)
  • Nelson JW, Yoo DS, Sampson JH, Isaacs RE, Larrier NA, Marks LB, Yin FF, Wu QJ, Wang Z, Kirkpatrick JK.  Stereotactic Body Radiotherapy for Lesions of the Spine and Paraspinal Regions. Int J Radiat Oncol Biol Phys. 2009 Apr 1;73(5):1369-1375.
  • Wang Z, Nelson JW, Yoo S, Wu QJ, Kirkpatrick JP, Marks LB, Yin FF. Refinement of Treatment Setup and Target Localization Accuracy Using Three-Dimensional Cone-Beam Computed Tomography for Stereotactic Body Radiotherapy. Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):571-7.
  • Wu QJ, Wang Z, Kirkpatrick JP, Chang Z, Meyer JJ, Lu M, Huntzinger C, Yin FF. Impact of collimator leaf width and treatment technique on stereotactic radiosurgery and radiotherapy plans for intra- and extracranial lesions. Radiat Oncol. 2009 Jan 21;4:3.
  • Igdem S, Spiegel DY, Efstathiou JA, Zietman AL, Miller R, Poortmans D, Unsal D. Prostatic Duct Adenocarcinoma: Clinical Characteristics, Treatment Options and Outcomes: A Rare Cancer Network Study. Proc. of the 51st Annual ASTRO Mtg.; 2009 Nov 1-5; Chicago, IL. I J Radiation Oncology. 2009. 75(3) Abstract #2266.
  • Efstathiou JA, Coen JJ, Spiegel DY, Skowronski RY, Kaufman DS, Heney NM, McDougal WS, McGovern FJ, Zietman AL, Shipley WU. Fifteen-year Outcomes of Selective Bladder Preservation by Combined Modality Therapy for Invasive Bladder Cancer. Proc. of the 2009 ASCO Genitourinary Cancers Symposium. 2009 Feb 26-28; Orlando, FL. Abstract #240.

2008

  • Shen H, Boyer M, and Cheng T. Flow cytometry based cell cycle measurement of mouse hematopoietic stem and progenitor cells by nucleic acid staining. Methods in Molecular Biology 2008; 430 77-86.
  • Boyer MJ and Cheng T. The CDK inhibitors: potential targets for therapeutic stem cell manipulations? Gene Therapy 2008 Jan, 15(2): 117-125. Epub 2007 Nov 8.
  • Boyle J, Wu A, Arora H, Paunesku T, Woloschak G. Use of titanium-dioxide nanoparticles for improved cytotoxicity of radiation therapy in vitro [abtract]. In: Medical Student Summer Research Project Poster Session, Northwestern University Feinberg School of Medicine; 2008; Chicago, IL
  • Chino JP, Marks LB. Prone positioning causes the heart to be displaced anteriorly within the thorax: implications for breast cancer treatment. Int J Radiat Oncol Biol Phys. 2008 Mar 1;70(3):916-920.
  • Czito BG, Cohen DP, Kelsey CR, Lockhart AC, Bendell JC, Willett CG, Petros WP, D'Amico TA, Truax R, Hurwitz HI. A phase I study of UFT/leucovorin, carboplatin, and paclitaxel in combination with external beam radiation therapy for advanced esophageal carcinoma. Int J Radiat Oncol Biol Phys. 2008 Mar 15;70(4):1066-72.
  • Ghafoori P, Marks LB, Vujaskovic Z, Kelsey CR. Radiation-induced lung injury. Assessment, management, and prevention. Oncology. 2008 Jan;22(1):37-47.
  • Kelsey CR, Marks LB, Wilson LD. Postoperative radiation therapy for lung cancer: where do we stand? Oncology (Williston Park). 2008 Mar;22(3):301-10; discussion 310, 314-5, 319.
  • Kirkpatrick JP, Meyer J.J., L.B. Marks. The Linear-Quadratic Model is Inappropriate to Model High-Dose per Fraction Effects. Sem Rad Oncol 2008 Oct;18(4):240-3.
  • Kirkpatrick JP, Rabbani Z.N., R.C. Bentley, M.E. Hardee, S. Karol, J. Meyer, E. Oosterwijk, L. Havrilesky, A. Alvarez Secord, Z.Vujaskovic, M.W. Dewhirst, E.L. Jones, Elevated CAIX Expression is Associated with an Increased Risk of Distant Failure in Early-Stage Cervical Cancer. Biomarker Insights, 2008;3:45-55.
  • Koontz BF, Miles EF, MD Rubio, JF Madden, SR Fisher, R Scher, and DM Brizel.  Pre-operative radiotherapy and bevacizumab for angiosarcoma of the head and neck: Two case studies. Head & Neck, 2008, 30(2):262-266
  • Meyer JJ, Czito BG, Willett CG. Intensity-modulated radiation therapy for gastrointestinal tumors. Curr Oncol Rep. 2008 May;10(3):206-11. Review.
  • Meyer JJ, Willett CG, Czito BG. Emerging role of intensity-modulated radiation therapy in anorectal cancer. Expert Rev Anticancer Ther. 2008 Apr;8(4):585-593
  • Meyer JJ, Willett CG, Czito BG. Is there a role for advanced radiation therapy technologies in the treatment of pancreatic adenocarcinoma? Future Oncol. 2008 Apr;4(2):241-55. Review.
  • Miles EF, Larrier NL, CR Kelsey, J Ma, J Hubbs, S Yoo, LB Marks. Intensity-modulated radiation therapy (IMRT) for resected mesothelioma: The Duke experience. Int J Radiat Oncol Biol Phys. 2008 Jul 15;71(4):1143-1150.
  • Miles EF, Lee WR. Hypofractionation for prostate cancer:  A critical review. Seminars in Radiation Oncology, 2008, 18(1):41-47.
  • Miles EF, Nelson JW, Alkaissi AK, Das S, Clough RW, Anscher MS, Oleson JR. Equivalent Uniform Dose (EUD), D90, and V100 correlation with biochemical control after low-dose-rate prostate brachytherapy for clinically low-risk prostate cancer. Brachytherapy, 2008, 7 (2):206-211.
  • Yin FF, Wang Z, Yoo S, Wu QJ, Kirkpatrick J, Larrier N, Meyer J, Willett CG, Marks LB. Integration of cone-beam CT in stereotactic body radiation therapy. Technol Cancer Res Treat. 2008 Apr;7(2):133-9.

2007

  • Czito BG, Kelsey CR, Hurwitz HI, Willett CG, Morse MA, Blobe GC, Fernando NH, D'Amico TA, Harpole DH, Honeycutt W, Yu D, Bendell JC. A Phase I study of capecitabine, carboplatin, and paclitaxel with external beam radiation therapy for esophageal carcinoma. Int J Radiat Oncol Biol Phys. 2007 Mar 15;67(4):1002-7.
  • Kasibhatla M, Steinberg P, Meyer J, Ernstoff MS, George DJ. Radiation therapy and sorafenib: clinical data and rationale for the combination in metastatic renal cell carcinoma. Clin Genitourin Cancer. 2007 Mar;5(4):291-4.
  • Kelsey CR, Chino JP, Willett CG, Clough RW, Hurwitz HI, Morse MA, Bendell JC, D'Amico TA, Czito BG. Paclitaxel-based chemoradiotherapy in the treatment of patients with operable esophageal cancer. Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):770-6.
  • Kelsey CR, Nelson JW, Willett CG, Chino JP, Clough RW, Bendell JC, Tyler DS, Hurwitz HI, Morse MA, Clary BM, Pappas TN, Czito BG. Duodenal adenocarcinoma: patterns of failure after resection and the role of chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2007 Dec 1;69(5):1436-41.
  • Meyer J, Czito B, Yin FF, Willett C. Advanced radiation therapy technologies in the treatment of rectal and anal cancer: intensity-modulated photon therapy and proton therapy. Clin Colorectal Cancer. 2007 Jan;6(5):348-56. Review.
  • Meyer JJ, Czito BG, Willett CG. Particle radiation therapy for gastrointestinal malignancies. Gastrointest Cancer Res. 2007;1(4 Suppl 2):S50-9.
  • Miles EF, Kelsey CR, Kirkpatrick JP, Marks LB. Estimating the magnitude and field-size dependence of radiotherapy-induced mortality and tumor control after postoperative radiotherapy for non-small-cell lung cancer: calculations from clinical trials. Int J Radiat Oncol Biol Phys. 2007 Jul 15;68(4):1047-52.